MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 2, 2007; DOI: 10.1124/mol.106.031534


0026-895X/07/7104-994-1005$20.00
Mol Pharmacol 71:994-1005, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.031534v1
71/4/994    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stoddart, L. A.
Right arrow Articles by Milligan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoddart, L. A.
Right arrow Articles by Milligan, G.

Uncovering the Pharmacology of the G Protein-Coupled Receptor GPR40: High Apparent Constitutive Activity in Guanosine 5'-O-(3-[35S]thio)triphosphate Binding Studies Reflects Binding of an Endogenous Agonist

Leigh A. Stoddart, Andrew J. Brown, and Graeme Milligan

Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom (L.A.S., G.M.); and Department of Screening and Compound Profiling, GlaxoSmithKline, Harlow, Essex, United Kingdom (A.J.B.)

In cells lacking expression of Ca2+-mobilizing G proteins, coexpression of human GPR40 and G{alpha}q allowed medium- and long-chain fatty acids to elevate intracellular [Ca2+]. This was also observed when human embryonic kidney (HEK) 293 cells were transfected with a GPR40-G{alpha}q fusion protein. The kinetic of elevation of intracellular [Ca2+] slowed with increasing fatty acid chain length, suggesting different ligand on-rates, whereas the addition of fatty acid-free bovine serum albumin reduced signals, presumably by binding the fatty acids. To allow effective ligand equilibration, GPR40-G{alpha}q was used in guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTP{gamma}S) binding assays. After expression of GPR40-G{alpha}q in HEK293 cells and membrane preparation basal binding of [35S]GTP{gamma}SinG{alpha}q immunoprecipitates was high and not elevated substantially by fatty acids. However, treatment of membranes with fatty acid-free bovine serum albumin reduced the basal [35S]GTP{gamma}S binding in a concentration-dependent manner and allowed the responsiveness and pharmacology at GPR40 of each of the fatty acids thiazolidinediones and a novel small-molecule agonist to be uncovered. Membranes of rat INS-1E cells that express GPR40 endogenously provided similar observations. The high apparent constitutive activity of GPR40-G{alpha}q was also reversed by a small-molecule GPR40 antagonist, and basal [35S]GTP{gamma}S binding was prevented by the selective G{alpha}q/G{alpha}11 inhibitor YM-254890. The current studies provide novel insights into the pharmacology of GPR40 and indicate that G protein-coupled receptors which respond to fatty acids, and potentially to other lipid ligands, can be occupied by endogenous agonists before assay and that this may mask the pharmacology of the receptor and may be mistaken for high levels of constitutive activity.


Received October 5, 2006; accepted January 2, 2007

Address correspondence to: Dr. G. Milligan, Davidson Building University of Glasgow, Glasgow G12 8QQ, Scotland, UK. E-mail: g.milligan{at}bio.gla.ac.uk




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. S. Sum, I. G. Tikhonova, S. Neumann, S. Engel, B. M. Raaka, S. Costanzi, and M. C. Gershengorn
Identification of Residues Important for Agonist Recognition and Activation in GPR40
J. Biol. Chem., October 5, 2007; 282(40): 29248 - 29255.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics